This inventor holds 6 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 1989-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (1989)
- Ibaraki, JP (1990 - 2006)
Company Filing History:
Years Active: 1989-2006
Title: Kazumi Ohtomo: Innovator in Pharmaceutical Composition and Liposome Preparations
Introduction
Kazumi Ohtomo is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized pharmaceutical compositions and liposome preparations. With a total of 6 patents to his name, Ohtomo's work has had a considerable impact on medical science.
Latest Patents
Ohtomo's latest patents include a stabilized pharmaceutical composition in lyophilized form. This composition comprises a cyclic polypeptide compound represented by a specific general formula, which includes various chemical components that enhance its stability. Another significant patent is for liposome preparations that contain a pipecolic acid derivative. This preparation is designed for rapid action in emergency situations, such as cerebral infarction, and is characterized by the absence of cholesterol as a stabilizer.
Career Highlights
Throughout his career, Kazumi Ohtomo has worked with prominent companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.
Collaborations
Ohtomo has collaborated with several professionals in his field, including Akihiro Kasai and Kiyoshi Okuda. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Kazumi Ohtomo's contributions to pharmaceutical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

